Page 86 - GPD-2-3

Gene & Protein in Disease Utilization of genetic testing in guiding mPTC treatment

health organization classification. Endocrinol Metab (Seoul), 11. Al-Qurayshi Z, Nilubol N, Tufano RP, et al., 2020, Wolf in
35(4): 696–715. sheep’s clothing: Papillary thyroid microcarcinoma in the
US. J Am Coll Surg, 230(4): 484–491.
https://doi.org/10.3803/enm.2020.807
https://doi.org/10.1016/j.jamcollsurg.2019.12.036
2. Saijo H, Kitamura Y, Takenaka H, et al., 2017, Occult thyroid
follicular carcinoma diagnosed as metastasis to the chest 12. Xu B, Scognamiglio T, Cohen PR, et al., 2017, Metastatic
wall. Intern Med, 56(15): 2033–2037. thyroid carcinoma without identifiable primary tumor
within the thyroid gland: A retrospective study of a rare
https://doi.org/10.2169/internalmedicine.56.8340
phenomenon. Hum Pathol, 65: 133–139.
3. Zheng W, Tan J, Zhang G, 2015, Extensive bone metastases
as the initial symptom of papillary thyroid microcarcinoma: https://doi.org/10.1016/j.humpath.2017.05.013
A case report. Exp Ther Med, 9(6): 2104–2108. 13. Yakushina VD, Lerner LV, Lavrov AV, 2018, Gene fusions in
thyroid cancer. Thyroid, 28(2): 158–167.
https://doi.org/10.3892/etm.2015.2423
https://doi.org/10.1089/thy.2017.0318
4. Schwaiger K, Koeninger F, Wimbauer J, et al., 2019, Occult
papillary thyroid cancer presenting as cystic metastasis of 14. Hsiao SJ, Nikiforov YE, 2014, Molecular approaches to
the lateral neck: A case report. Medicine (Baltimore), 98(30): thyroid cancer diagnosis. Endocr Relat Cancer, 21: T301–
e16659. T313.
https://doi.org/10.1097/MD.0000000000016659 https://doi.org/10.1530/erc-14-0166
5. Pollack R, Mazeh H, 2021, Active surveillance of thyroid 15. Romei C, Elisei R, 2012, RET/PTC translocations and
microcarcinoma-can this approach be safely implemented clinico-pathological features in human papillary thyroid
worldwide? J Surg Res, 258: 145–152. carcinoma. Front Endocrinol (Lausanne), 3: 54.
https://doi.org/10.1016/j.jss.2020.08.061 https://doi.org/10.3389/fendo.2012.00054
6. Vaccarella S, Franceschi S, Bray F, et al., 2016, Worldwide 16. Viglietto G, Chiappetta G, Martinez-Tello FJ, et al., 1995,
thyroid-cancer epidemic? The Increasing impact of RET/PTC oncogene activation is an early event in thyroid
overdiagnosis. N Engl J Med, 375(7): 614–617. carcinogenesis. Oncogene, 11(6): 1207–1210.

https://doi.org/10.1056/NEJMp1604412 17. Lan X, Bao H, Ge X, et al., 2020, Genomic landscape
of metastatic papillary thyroid carcinoma and novel
7. Haugen BR, Alexander EK, Bible KC, et al., 2016, 2015
American thyroid association management guidelines biomarkers for predicting distant metastasis. Cancer Sci,
for adult patients with thyroid nodules and differentiated 111(6): 2163–2173.
thyroid cancer: The American thyroid association guidelines https://doi.org/10.1111/cas.14389
task force on thyroid nodules and differentiated thyroid 18. Musholt TJ, Staubitz JI, Cámara RJ, et al., 2019, Detection of
cancer. Thyroid, 26(1): 1–133.
RET rearrangements in papillary thyroid carcinoma using
https://doi.org/10.1089/thy.2015.0020 RT-PCR and FISH techniques-a molecular and clinical
analysis. Eur J Surg Oncol, 45(6): 1018–1024.
8. Sugitani I, Ito Y, Takeuchi D, et al., 2021, Indications and
strategy for active surveillance of adult low-risk papillary https://doi.org/10.1016/j.ejso.2018.11.009
thyroid microcarcinoma: Consensus statements from 19. González HE, Martínez JR, Vargas-Salas S, et al., 2017,
the Japan association of endocrine surgery task force on A 10-gene classifier for indeterminate thyroid nodules:
management for papillary thyroid microcarcinoma. Thyroid, Development and multicenter accuracy study. Thyroid,
31(2): 183–192. 27(8): 1058–1067.
https://doi.org/10.1089/thy.2020.0330
https://doi.org/10.1089/thy.2017.0067
9. Haser GC, Tuttle RM, Su HK, et al., 2016, Active surveillance 20. Steward DL, Carty SE, Sippel RS, et al., 2019, Performance
for papillary thyroid microcarcinoma: New challenges and of a multigene genomic classifier in thyroid nodules with
opportunities for the health care system. Endocr Pract, indeterminate cytology: A prospective blinded multicenter
22(5): 602–611. study. JAMA Oncol, 5(2): 204–212.
https://doi.org/10.4158/ep151065.ra
https://doi.org/10.1001/jamaoncol.2018.4616
10. Orlando G, Scerrino G, Corigliano A, et al., 2022, Papillary 21. Labourier E, Shifrin A, Busseniers AE, et al., 2015, Molecular
thyroid microcarcinoma: Active surveillance against testing for miRNA, mRNA, and DNA on fine-needle
surgery. Considerations of an Italian working group from a aspiration improves the preoperative diagnosis of thyroid
systematic review. Front Oncol, 12: 859461.
nodules with indeterminate cytology. J Clin Endocrinol
https://doi.org/10.3389/fonc.2022.859461 Metab, 100(7): 2743–2750.

Volume 2 Issue 3 (2023) 5 https://doi.org/10.36922/gpd.0371